Systemic Akt1 ablation, on the other hand, blocks metastasis by inhibiting the mobilization and survival of tumor-associated neutrophils, which have pro-metastatic properties; ablating Akt1 in neutrophils alone is sufficient to impede metastasis [263]. The gene discussed is AKT1; the disease is neoplasm.